Ineffectiveness of Tigecycline against Persistent Borrelia burgdorferi, Antibicrobial Agents and Chemotherapy

Alzhiemer's Disease: A Neurospirochetosis

Conflict of Interest in Clinical Practice Guideline
Development: A Systematic Review

Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection

Intruders below the Radar: Molecular Pathogenesis of Bartonella spp.

Changing Epidemiology of Ixodes Scapularis -Borne Diseases in Minnesota

Neuropsychiatric Lyme Disease

Optic Neuropathy in Children with Lyme Disease

Prolonged Antibiotic Therapy in PCR Confirmed Persistent Lyme Disease

Prevalence of Lyme Arthritis in Minnesota Department of Health

Review of Lyme Neuroborreliosis

Serologic Testing in Lyme Disease

The Management of Ixodes scapularis Bites in the Upper Midwest 

The Need for Clinical Judgment in the Diagnosis and Treatment of Lyme Disease



Challenges to IDSA Guidelines

Dr. Betty Maloney is the medical advisor for Minnesota Lyme Association. In that role, her goal is to provide accurate scientific information regarding tick-borne diseases to the medical community and the lay public.

Dr. Maloney is a family physician from Wyoming, MN. She graduated from the University of MN Medical School and completed her residency in family medicine at the University. She is a member of the American Academy of Family Practice, the Minnesota Academy of Family Practice and the International Lyme and Associated Diseases Society (ILADS).

Based on her review of the literature, she has developed individual continuing medical education courses on Lyme disease for nurses, chiropractors and physicians.

Dr. Maloney wrote several challenges to the 2006 IDSA guidelines on behalf of ILADS. 



Challenge to the Recommendation Restricting the Use of Clinical Judgment.

Challenge to the Recommendation on the Prophylaxis of Lyme Disease

Challenge to the Recommendation Restricting Specific Therapeutic Options in the Treatment of Lyme Disease

Challenge to the Recommendation Limiting the Duration of Treatment for Late Neurologic Lyme Disease

Challenge to the Recommendation Regarding Post- treatment Lyme Disease Symptoms

Other Challengers